Skip to content

Clinical trials

Phase 1/2 Hematologic Neoplasms trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Phase: Phase 1/2 Status: Unknown status Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20092
20132
20141
20162
20173
20192
20202
20212
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status20

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese PLA General Hospital4
A.O. Ospedale Papa Giovanni XXIII2
Cellect Biotechnology1
Ciusss de L'Est de l'Île de Montréal1
Curon Biopharmaceutical (Australia) Co Pty Ltd1
Glycostem Therapeutics BV1
Hadassah Medical Organization1
Hospices Civils de Lyon1
Sichuan University1
Smart Immune SAS1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms20
Lymphoma, Mantle-Cell4
Leukemia, Lymphocytic, Chronic, B-Cell3
Leukemia, Myeloid, Acute3
Lymphoma, Follicular3
Lymphoma, Large B-Cell, Diffuse3
Graft vs Host Disease2
Leukemia2
Leukemia, Prolymphocytic2
Multiple Myeloma2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.